LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trialXue Feng, Lai Wei, Jixian Gao et al.|Journal of Hepatology|2024Cited by 27
Degradation of CIP by circulating water-electrode DBD plasma: Degradation performance, key reactive species, and pathway analysisXiaomei Yao, Jixian Gao, Minghao Xu et al.|Separation and Purification Technology|2025Cited by 11
Efficacy and Safety of HSK31679 in Asian Patients With MASLD: A Randomized Controlled TrialFeng Xue, Lai Wei, Wei Ma et al.|Clinical Gastroenterology and Hepatology|2025Cited by 2